GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » PB Ratio

Fuan Pharmaceutical (Group) Co (SZSE:300194) PB Ratio : 1.14 (As of May. 28, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-28), Fuan Pharmaceutical (Group) Co's share price is ¥4.11. Fuan Pharmaceutical (Group) Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.59. Hence, Fuan Pharmaceutical (Group) Co's PB Ratio of today is 1.14.

The historical rank and industry rank for Fuan Pharmaceutical (Group) Co's PB Ratio or its related term are showing as below:

SZSE:300194' s PB Ratio Range Over the Past 10 Years
Min: 0.88   Med: 1.69   Max: 6.27
Current: 1.14

During the past 13 years, Fuan Pharmaceutical (Group) Co's highest PB Ratio was 6.27. The lowest was 0.88. And the median was 1.69.

SZSE:300194's PB Ratio is ranked better than
74.11% of 958 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SZSE:300194: 1.14

During the past 12 months, Fuan Pharmaceutical (Group) Co's average Book Value Per Share Growth Rate was 6.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 4.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Fuan Pharmaceutical (Group) Co was 101.40% per year. The lowest was -9.90% per year. And the median was 3.00% per year.

Back to Basics: PB Ratio


Fuan Pharmaceutical (Group) Co PB Ratio Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co PB Ratio Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.65 1.43 1.63 1.09 1.26

Fuan Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.14 1.25 1.26 1.06

Competitive Comparison of Fuan Pharmaceutical (Group) Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's PB Ratio falls into.



Fuan Pharmaceutical (Group) Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Fuan Pharmaceutical (Group) Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=4.11/3.594
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Fuan Pharmaceutical (Group) Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Executives
Wu Xiong Hui Executives
Huang Tao Directors, executives
Feng Jing Executives
Yu Xue Song Directors, executives
Hong Rong Chuan Executives
Tang Qin Secretary, Director
Wang Tian Xiang Director
Sun Yong Ping Executives
Jiang Chen Directors, executives
Huang Dao Fei Supervisors
Wen Min Director
Zhou Xu Dong Executives
Zhou Zhong Sheng Supervisors

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines